Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists
1996

Patient Preferences for Treatment in Testicular Cancer

Sample size: 202 publication Evidence: moderate

Author Information

Author(s): MH Cullen, LJ Billingham, J Cook, CM Woodroffe

Primary Institution: Birmingham Oncology Centre, University Hospital, Birmingham NHS Trust

Hypothesis

What management approach do patients prefer for stage I non-seminomatous germ cell tumours of the testis?

Conclusion

Patients show a wide variability in treatment preferences, often favoring options they have prior experience with.

Supporting Evidence

  • 207 subjects participated in the study across nine different groups.
  • Patients with prior experience tended to favor the treatment they had received.
  • 44% of newly diagnosed patients preferred the doctor to decide on treatment.

Takeaway

This study asked cancer patients how they would choose between two treatment options, and found that many want their doctor to help decide.

Methodology

Questionnaires were distributed to various groups including newly diagnosed patients and oncologists to assess treatment preferences based on hypothetical recurrence risks.

Potential Biases

Potential bias due to the presence of a research nurse who administered the questionnaires.

Limitations

The study's findings may not be generalizable beyond the specific populations surveyed.

Participant Demographics

Participants included newly diagnosed patients, patients with prior treatment experience, medical students, firemen, and oncologists.

Statistical Information

P-Value

0.06

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication